A
licenseNot graded
qualityC
maintenanceEnables rare disease clinicians and trial teams to generate traceable drug-repurposing briefs by querying public disease, target, approved-drug, clinical-trial, and literature databases through five tools, with cited evidence and stated limitations.
MIT